A2-Ai
Home
Leadership
Blog
Careers
Get in touch
All posts Tag / FDA

Tags

ADMEAgingAIanimal testingapproval processclinical pharmacologyclinical trialsClinical Trialscloud platformdata analysisdose escalationdrug development
see all RSS

Simonne Bruck

Business Manager

April 30, 2025

MIDD - FDA Has Officially Announced Their Roadmap to Phase Out Animal Testing for Monoclonal Antibodies

news

Eric Storms

Director of Business Development

November 14, 2025

Accelerating FDA Approval with MIDD: How A2-Ai Secured a New Dose Without a Phase 3 Trial

servicescase studies

Simonne Bruck

Business Manager

February 28, 2025

IND Services - We Support and Assist You in IND Applications to Streamline the FDA Approval Process

services

Links

Home Leadership Careers Contact Blog

Science

FDA Project Optimus Preclinical Support Clinical Pharmacology Pharmacometrics Education

Technology

Overview A2-Ai Cloud Alexandria PharmaSage

Resources

Attributions

Community

LinkedIn GitHub RSS
A2-Ai

A2-Ai is a premier full-service consultancy run by leaders who put science and patients first, with a focus on providing true value to our clients.

® A2-Ai LLC 2023

2723 S. State Street
Suite 310
Ann Arbor, MI 48104